Ocriplasmin
Generic Name: ocriplasmin
Manufactured by THROMBOGENICS, INC. Dosage form: INJECTABLE. Route: INTRAVITREAL. Active ingredients: OCRIPLASMIN (2.5MG/ML). Application: BLA125422.
Overview
Manufactured by THROMBOGENICS, INC. Dosage form: INJECTABLE. Route: INTRAVITREAL. Active ingredients: OCRIPLASMIN (2.5MG/ML). Application: BLA125422.
Dosage
Available as injectable for intravitreal use.
Related Medications
Dulaglutide
dulaglutide
GLP-1 Receptor Agonist [EPC]
11 DESCRIPTION Dulaglutide is a human GLP-1 receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to the Fc portion of a modified human immunoglobulin G4 (IgG4) heavy chain by a small peptide linker and is produced using mammalian cell (Chinese hamster ovary) culture. The GLP-1 analog portion of dulaglutide is 90% homologous to native human GLP-1 (7-37).
Tenapanor
tenapanor
11 DESCRIPTION XPHOZAH (tenapanor) tablets contain tenapanor hydrochloride as an active ingredient. Tenapanor hydrochloride is a sodium/hydrogen exchanger 3 (NHE3) inhibitor for oral use. The chemical name for tenapanor hydrochloride is 12,15-Dioxa-2,7,9-triazaheptadecanamide, 17-[[[3-[(4S)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl]phenyl]sulphonyl]amino]-N-[2-[2-[2-[[[3-[(4S)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl]phenyl]sulphonyl]amino]ethoxy]ethoxy]ethyl]-8-ox
Glo Skin Beauty Clear Skin Spot Treatment
glo skin beauty clear skin spot treatment
Purpose Acne Treatment
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.